Ind-Swift Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2025 ,inter alia, to consider and approve Standalone and Consolidated ....
INDSWFTLAB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Ind-Swift Laboratories has informed BSE that its Board of Directors will meet on Wednesday, 13 August 2025 to consider and approve the Standalone and Consolidated Un-Audited Financial Results for the quarter ended 30 June 2025 (Q1 FY26). The filing is a standard regulatory disclosure under SEBI's Listing Regulations. No financial figures or outcomes have been disclosed yet, as the meeting is still upcoming. The company also reminds exchanges that the trading window closure was already communicated on 30 June 2025.
This is a routine procedural announcement with no direct impact on the stock price. Investors should watch for the actual Q1 FY26 results, which will be released after the 13 August board meeting and could influence trading sentiment.